Exosome as the Prognostic and Predictive Biomarker in EBC Patients
NCT05955521 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2023-07-21
Summary
This study is the experimental study for serial ctDNA and exosome evaluation in EBC patients
Conditions
Interventions
- PROCEDURE
-
exosome and ctDNA evaluation
Serial exosome and ctDNA evaluation during follow up period between neoadjuvant chemotherapy and surveillance after curative surgery.
Sponsors & Collaborators
-
Samsung Medical Center
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- SCREENING
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-05-01
- Primary Completion
- 2023-07-01
- Completion
- 2028-07-01
Countries
- South Korea
Study Locations
More Related Trials
-
Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment
NCT06087120 ·Status: RECRUITING
-
Comparative Genomic and Genetic Analysis of Paired Primary Breast - Metastatic Tumor Specimens Using High-throughput Platforms
NCT01227733 ·Status: UNKNOWN
-
Clinical Study of Glycosylated Extracellular Vesicles for Early Diagnosis of Breast Cancer
NCT05417048 ·Status: UNKNOWN
-
A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients at High Risk for Breast Cancer
NCT06672302 ·Status: RECRUITING
-
T-DM1 in HER2-positive Metastatic/Relapsed Breast Cancer
NCT04202328 ·Status: UNKNOWN
-
Microbiome Immunotherapy Neoadjuvant Assessment
NCT06709651 ·Status: RECRUITING
-
Identification of Genes That Predict Local Recurrence in Samples From Patients With Breast Cancer Treated on NSABP-B-28
NCT01420185 ·Status: UNKNOWN
-
Prospective Breast Cancer Biospecimen Collection
NCT04074720 ·Status: RECRUITING
-
Breast Cancer Survivorship Biorepository
NCT05786664 ·Status: RECRUITING
-
Prospective Radiomics Study for Breast Cancer
NCT06095414 ·Status: COMPLETED
-
Radiological and Biological Tumoural and Peri-tumoural Factors in Neoadjuvant Endocrine-treated Breast Cancers
NCT02701348 ·Status: COMPLETED ·Phase: NA
-
Oncologic Outcomes and Toxicities of Salvage Treatment in Patients With Locoregionally Recurrent Breast Cancer
NCT05933733 ·Status: RECRUITING
-
Prospective Validation Trial of Circulating Tumor Cells (CTCs) in Women With Metastatic Breast Cancer
NCT00493350 ·Status: COMPLETED
-
Breast Cancer Molecular Analysis Protocol
NCT01855503 ·Status: COMPLETED
-
Extracellular Vesicles in Breast Cancer Patientsin Undergone Neoadjuvant Chemotherapy
NCT05831397 ·Status: RECRUITING
-
Genomic Markers for Measuring Breast Cancer Response to Neoadjuvant Chemotherapy
NCT03709134 ·Status: COMPLETED
-
Comparative Study Between Shear and Strain Elastography in Monitoring the Response to NAC in Breast Cancer Patients
NCT05852743 ·Status: NOT_YET_RECRUITING
-
Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients
NCT01276899 ·Status: COMPLETED
-
Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer
NCT00001496 ·Status: COMPLETED
-
Tumour Necrosis Factor Release in Locally Advanced Breast Cancer Patients Receiving Neoadjuvant Docetaxel
NCT01539876 ·Status: WITHDRAWN ·Phase: PHASE1
-
the New Geneswell BCT in Vitro Diagnosis of Breast Cancer Prognosis
NCT04179318 ·Status: UNKNOWN
-
Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer
NCT01514565 ·Status: UNKNOWN
-
Cohort Study of Patients With HER2-negative MBC and BRCA 1/2 Pathogenic Mutation
NCT04368442 ·Status: UNKNOWN
-
Positive Node Traced Before Neoadjuvant Chemotherapy (NAC)
NCT03355261 ·Status: COMPLETED ·Phase: NA
-
Tracking Triple-negative Breast Cancer Evolution Through Therapy
NCT03077776 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA